Form 4: Opus Genetics Director Receives Equity for Board Service

Opus Genetics Director Adrienne L Graves was granted 23,643 shares of common stock in lieu of cash for 2026 board services, increasing her beneficial ownership to 103,147 shares.

Summary

• Adrienne L Graves, a Director of Opus Genetics, Inc. (IRD), was granted 23,643 shares of common stock.
• The shares were granted on January 1, 2026, in lieu of cash compensation for her board services for the year 2026.
• The number of shares was determined by dividing the aggregate retainer for board services by the average fair market value of a share of common stock the day prior to the grant date, which was $1.99 per share.
• The total value of the shares granted is approximately $47,049.57 (23,643 shares * $1.99/share).
• Following this transaction, Adrienne L Graves beneficially owns a total of 103,147 shares of Opus Genetics common stock.

Sentiment

Score: 6

Explanation: Slightly positive, as it indicates a director's continued commitment and increased alignment with shareholder interests through equity ownership, which is a standard and healthy corporate governance practice.

Positives

• The grant of common stock to a director aligns their interests more closely with those of the shareholders, as their compensation is tied to the company's equity performance.
• An increase in a director's beneficial ownership can signal confidence in the company's future prospects.

Future Outlook

This filing does not contain forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

Equity compensation for board services is a common practice across various industries, including biotechnology and pharmaceuticals, to align the interests of directors with those of shareholders and to conserve cash.

Comparison to Industry Standards

• The practice of compensating directors with equity in lieu of cash is a standard corporate governance practice, widely adopted by public companies to foster long-term commitment and align director incentives with shareholder value creation.
• The valuation method, using the average fair market value of common stock, is a typical approach for determining equity grants.

Related Party Transactions

• The grant of 23,643 shares of common stock to Adrienne L Graves, a Director, for board services constitutes a related party transaction, as it involves compensation from the company to a member of its board.

Stakeholder Impact

• Shareholders: The increased equity ownership by a director can be viewed positively, as it strengthens alignment between management and shareholder interests.
• Employees: No direct impact on employees is indicated by this filing.

Key Dates

Keywords

Opus Genetics, IRD, Adrienne L Graves, Director compensation, Equity grant, Common stock, Insider transaction, Beneficial ownership, Form 4